BioSig Technologies, Inc. STEX Warrant Modification Expense
Warrant Modification Expense at other companies
Other financials
Where this comes from
Reported directly by BioSig Technologies, Inc. in its filing.
Tagged under the XBRL concept STEX:WarrantModificationExpense.
The official record: BioSig Technologies, Inc.’s 10-K, filed March 31, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioSig Technologies, Inc.'s warrant modification expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioSig Technologies, Inc.'s warrant modification expense?
- BioSig Technologies, Inc. (STEX) reported warrant modification expense of $3.75K in Q4 2024.
- What does warrant modification expense mean?
- Represents the non-cash expense recognized when the terms of existing warrants are modified, resulting in an incremental increase in their fair value. This metric highlights the cost associated with adjusting equity-linked instruments, often used to incentivize holders or restructure capital. It is important for assessing the impact of capital structure management on reported earnings.